학술논문
Benefit of interferon -1a on MSFC progression in secondary progressive MS
Document Type
Article
Author
Source
Neurology (Ovid); September 2002, Vol. 59 Issue: 5 p679-687, 9p
Subject
Language
ISSN
00283878; 1526632X
Abstract
Interferon -1a (IFN-1a, Avonex) is efficacious in relapsing forms of MS. Studies of other IFN preparations in secondary progressive MS (SPMS) yielded conflicting results. This study was undertaken to determine whether IFN-1a slowed disease progression in SP-MS.